Europe Discovers the Molecules. Who Builds the Companies? AI, Drug Discovery and the Spin-Off Gap
AI is compressing the cost of discovering a drug. Europe’s real test is turning that science into fundable spin-offs and startups. The data, the gap, and a practical playbook.
